Update: Philips Q3 Net Income Decreases, Sales Increases; 2026 Sales Growth Outlook Maintained

04:09 AM EST, 11/03/2026 (MT Newswires) -- (Updates to add details of its agreement with US DOJ in fifth and sixth paragraph.) Koninklijke Philips N.V (PHG) reported Q3 net income from continuing operations Tuesday of 0.03 euros ($0.03) per diluted share, down from 0.19 euros a year earlier. Sales for the quarter ended Sept. 30 were 4.39 billion euros, up from 4.30 billion euros a year earlier. Analysts expected 4.47 billion euros. For 2026, the Dutch electronics and medical devices maker continues to expect sales growth of 3% to 4.5%. Additionally, Philips said its Respironics unit reached an agreement in principle with the US Department of Justice to resolve previously disclosed criminal and civil investigations related to the Respironics recall. The company said it recorded a provision of 288 million euros in Q3. The settlement remains subject to final documentation, with payment expected in Q1 2027, it added. Shares of the company were flat in recent premarket activity.